David E. Selk

422 total citations
5 papers, 371 citations indexed

About

David E. Selk is a scholar working on Organic Chemistry, Pharmacology and Molecular Biology. According to data from OpenAlex, David E. Selk has authored 5 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Organic Chemistry, 3 papers in Pharmacology and 2 papers in Molecular Biology. Recurrent topics in David E. Selk's work include Chemical synthesis and alkaloids (4 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Medicinal Plants and Neuroprotection (1 paper). David E. Selk is often cited by papers focused on Chemical synthesis and alkaloids (4 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Medicinal Plants and Neuroprotection (1 paper). David E. Selk collaborates with scholars based in United States. David E. Selk's co-authors include Gina M. Bores, Douglas K. Rush, Francis P. Huger, Fernando Camacho, Hugo M. Vargas, Wayne W. Petko, Abdul Mutlib, Raymond W. Kosley, Luther Davis and Stephen M. Sorensen and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Neuropharmacology.

In The Last Decade

David E. Selk

5 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David E. Selk United States	5	202	155	111	52	52	5	371
Gina M. Bores United States	10	316 1.6×	246 1.6×	184 1.7×	70 1.3×	60 1.2×	15	531
Wayne W. Petko United States	10	240 1.2×	224 1.4×	151 1.4×	54 1.0×	60 1.2×	17	542
Jann A. Nielsen United States	9	223 1.1×	91 0.6×	167 1.5×	172 3.3×	28 0.5×	12	443
Mariana G. Fronza Brazil	15	113 0.6×	178 1.1×	107 1.0×	56 1.1×	26 0.5×	34	549
Vijay Benade India	14	141 0.7×	102 0.7×	185 1.7×	127 2.4×	27 0.5×	53	581
Adrian Podkowa Poland	15	246 1.2×	122 0.8×	210 1.9×	205 3.9×	56 1.1×	23	642
Xi-can Tang China	13	262 1.3×	80 0.5×	172 1.5×	52 1.0×	67 1.3×	34	517
Shawn B. Jones United States	4	193 1.0×	125 0.8×	164 1.5×	86 1.7×	26 0.5×	8	447
Douglas K. Rush United States	13	360 1.8×	221 1.4×	246 2.2×	248 4.8×	76 1.5×	27	815
Yuka Kuriya Japan	8	319 1.6×	59 0.4×	167 1.5×	156 3.0×	81 1.6×	8	480

Countries citing papers authored by David E. Selk

Since Specialization

Citations

This map shows the geographic impact of David E. Selk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Selk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Selk more than expected).

Fields of papers citing papers by David E. Selk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Selk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Selk. The network helps show where David E. Selk may publish in the future.

Co-authorship network of co-authors of David E. Selk

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Selk. A scholar is included among the top collaborators of David E. Selk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Selk. David E. Selk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Black, Mark D., David E. Selk, Janice M. Hitchcock, Joseph G. Wettstein, & Stephen M. Sorensen. (1999). On the effect of neonatal nitric oxide synthase inhibition in rats: a potential neurodevelopmental model of schizophrenia. Neuropharmacology. 38(9). 1299–1306. 67 indexed citations

2.

Smith, Craig P., Gina M. Bores, Wayne W. Petko, et al.. (1997). Pharmacological Activity and Safety Profile of P10358, a Novel, Orally Active Acetylcholinesterase Inhibitor for Alzheimer’s Disease. Journal of Pharmacology and Experimental Therapeutics. 280(2). 710–720. 35 indexed citations

3.

Klein, Joseph, Gina M. Bores, Fernando Camacho, et al.. (1997). Synthesis and preliminary structure-activity relationships of 1-[(3-fluoro-4-pyridinyl)amino]-3-methyl-1H-indol-5-yl methyl carbamate (P10358), a novel acetylcholinesterase inhibitor. Bioorganic & Medicinal Chemistry Letters. 7(2). 157–162. 19 indexed citations

4.

Bores, Gina M., Francis P. Huger, Wayne W. Petko, et al.. (1996). Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine.. Journal of Pharmacology and Experimental Therapeutics. 277(2). 728–738. 222 indexed citations

5.

Fink, David M., et al.. (1995). Synthesis and Evaluation of 5-Amino-5,6,7,8-tetrahydroquinolinones as Potential Agents for the Treatment of Alzheimer's Disease. Journal of Medicinal Chemistry. 38(18). 3645–3651. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact